Yatharth Hospital & Trauma Care Services (YATHARTH) Q1 24/25 earnings summary

Executive summary

• Q1 FY25 revenue rose 37% year-over-year to Rs. 2,118 mn, with EBITDA up 30% and PAT up 60% year-over-year.

• Unaudited standalone and consolidated financial results for the quarter ended June 30, 2024, were approved by the Board on August 13, 2024.

• Bed capacity increased by 200 to 1,605 beds, with Faridabad hospital operationalized in May 2024.

• Occupancy improved to 61% from 51% year-over-year, and ARPOB increased 9% to Rs. 30,551.

• Strategic focus on expanding super specialties, capacity, and leveraging technology to drive growth.

Financial highlights

• Consolidated revenue from operations for Q1 FY25 was ₹2,117.83 million, up from ₹1,545.07 million in Q1 FY24 (year-over-year growth).

• EBITDA was Rs. 537 mn (25.3% margin), up 30% year-over-year but margin declined 146 bps.

• PAT stood at Rs. 304 mn, up 60% year-over-year; PAT margin improved 203 bps to 14.3%.

• PBT was Rs. 430 mn, up 46% year-over-year; financial cost declined 51% year-over-year.

• Total cash as of June 2024 was Rs. 1,826 mn.

Outlook and guidance

• Targeting bed capacity expansion to 2,800–3,000 beds by FY28 through greenfield and brownfield projects.

• Plans to expand bed capacity at Greater Noida and Noida Extension over the next 24–36 months.

• Focus on increasing share of super specialties, oncology, and robotics to drive ARPOB.

• Strategic initiatives to grow self-pay, private insurance, and international business.